Alkermes To Put Its Long-Acting Stamp On Trusted Blockbusters, Starting With Abilify

Alkermes unveils patented, monthly injectable form of aripiprazole, developed without Bristol/Otsuka. Up next: Pfizer/Amgen's Enbrel.